Roche Pharma launches clinical trial excellence project in India EP News Bureau Oct 20, 2023 Program partners with government hospitals to strengthen drug development in the country
Affordability is tied to quality Viveka Roychowdhury Aug 17, 2023 In a freewheeling conversation, Leena Menghaney, Regional Head, MSF Access Campaign explains to Viveka Roychowdhury how the Covid…
Novo Nordisk to acquire Inversago Pharma for up to $1.075 bn EP News Bureau Aug 11, 2023 The acquisition of Inversago includes the company’s lead development asset INV-202, an oral CB1 inverse agonist
Centhaquine set to enter US-FDA approved Phase 3 clinical trial in US and Europe EP News Bureau Aug 2, 2023 Pharmazz India obtained marketing authorization for the management of Hypovolemic shock Lyfaquin (INN: Centhaquine) in India in…
Merck and Moderna initiate phase 3 study evaluating V940 EP News Bureau Jul 27, 2023 V940-001 is the first phase 3 study of a planned comprehensive clinical development program being initiated following the positive…
Neurogene and Neoleukin announce definitive merger agreement EP News Bureau Jul 20, 2023 Upon completion of the merger, which is subject to approval by Neurogene and Neoleukin stockholders, the combined company is…
USFDA approves Sanofi-AstraZeneca’s preventive RSV therapy for babies EP News Bureau Jul 19, 2023 The companies plan to make Beyfortus available in the United States ahead of the upcoming RSV season, Sanofi said, adding that it…
BridgeBio Pharma’s heart disease drug meets main goal in late-stage study Reuters Jul 18, 2023 The company said no safety concerns were identified in patients, adding that it intends t submit marketing applications to the US…
Sathgen Therapeutics announces completion of first cohort in phase 1 clinical trial with anti-cancer… EP News Bureau Jul 17, 2023 Sathgen aims to develop MSP008-22 for difficult-to-treat cancers, starting with triple negative breast cancer (TNBC) and prostate…
Transgender inclusion in healthcare: Breaking barriers and creating equitable clinical trials Jahanara Nayar Rahuldev Jul 7, 2023 Jahanara Nayar Rahuldev, Diversity Equity Inclusion India Lead, Parexel accentuates that diversity, equity and inclusion in…